Elanco Animal Health Incorporated Stock price

Equities

ELAN

US28414H1032

Pharmaceuticals

Real-time Estimate Cboe BZX 01:20:44 2024-02-26 pm EST 5-day change 1st Jan Change
16.5 USD +0.82% Intraday chart for Elanco Animal Health Incorporated +1.80% +10.34%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2023 * 4.39B Sales 2024 * 4.51B Capitalization 8.07B
Net income 2023 * -1.19B Net income 2024 * -89M EV / Sales 2023 * 3.09 x
Net Debt 2023 * 5.47B Net Debt 2024 * 5.19B EV / Sales 2024 * 2.94 x
P/E ratio 2023 *
-6.83 x
P/E ratio 2024 *
-98.6 x
Employees 9,370
Yield 2023 *
-
Yield 2024 *
-
Free-Float 99.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.56%
1 week+0.93%
Current month+10.58%
1 month+7.38%
3 months+35.27%
6 months+33.72%
Current year+9.40%
More quotes
1 week
15.14
Extreme 15.14
16.88
1 month
14.35
Extreme 14.35
16.88
Current year
13.91
Extreme 13.91
16.88
1 year
7.88
Extreme 7.88
16.88
3 years
7.88
Extreme 7.88
37.49
5 years
7.88
Extreme 7.88
37.49
10 years
7.88
Extreme 7.88
37.61
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 18-06-30
Director of Finance/CFO 52 18-12-13
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 62 19-05-07
Director/Board Member 68 19-03-10
Director/Board Member 66 18-08-31
More insiders
Date Price Change Volume
24-02-26 16.44 +0.43% 5 851 415
24-02-23 16.37 +1.36% 7,686,324
24-02-22 16.15 -0.06% 6,087,849
24-02-21 16.16 +0.06% 4,673,163
24-02-20 16.15 -0.62% 4,257,023

Delayed Quote Nyse, February 26, 2024 at 11:15 am EST

More quotes
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its Farm Animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
16.37 USD
Average target price
15.77 USD
Spread / Average Target
-3.65%
Consensus
  1. Stock
  2. Equities
  3. Stock Elanco Animal Health Incorporated - Nyse
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW